Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transfection of K-rasAsp12 cDNA markedly elevates IL-1β- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells

Abstract

Activating mutations of K-ras are frequent in colon tumors and aberrant crypt foci, and may play important roles in colon carcinogenesis. Here, we investigated the effects of a K-ras codon 12 mutation on inducible nitric oxide synthase (iNOS) expression. When rat intestinal epithelial cells (IEC-6) were transfected with K-rasAsp12 cDNA, the iNOS expression linked to interleukin-1β (IL-1β) or lipopolysaccharide (LPS) treatment was markedly increased and prolonged. In contrast, it was only very faint and transient in cells transfected with the control vector or K-rasWT. Electrophoretic mobility-shift assays demonstrated that NF-κB binding activity induced by IL-1β or LPS was also increased in K-rasAsp12-transfected cells, along with the binding of CREB-1, CREM-1, ATF-1, ATF-2, and Jun D to a cAMP-responsive element (CRE)-like site and the binding of C/EBPβ to a C/EBP-binding consensus site. Furthermore, the anchorage-independent growth of K-rasAsp12-transfected cells was markedly increased by IL-1β or LPS treatment, and decreased by ONO-1714, an iNOS inhibitor. In addition, tumor growth in nude mice injected with K-rasAsp12-transfected cells was significantly suppressed by NOS inhibition with 50 p.p.m. ONO-1714 or 100 p.p.m. L-NG-nitroarginine methyl ester. These results suggest that an activating mutation of K-ras can markedly enhance the iNOS expression mediated by IL-1β or LPS, through the activation of promoters on NF-κB, C/EBP, and CRE-like sites, and that nitric oxide contributes to the colony formation and tumor growth of K-ras-transformed cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adjei AA . (2001). J. Natl. Cancer Inst., 93, 1062–1074.

  • Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PS, Billiar TR and Harris CC . (1998). Cancer Res., 58, 334–341.

  • Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS and Sonenshein GE . (2000). Mol. Cell. Biol., 20, 5381–5391.

  • Bhat NR, Feinstein DL, Shen Q and Bhat AN . (2002). J. Biol. Chem., 277, 29584–29592.

  • Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR and Brasitus TA . (2000). Cancer Res., 60, 4602–4609.

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ . (1998). Oncogene, 17, 1395–1413.

  • Cirillo G, Casalino J, Vallone D, Caracciolo A, De Cesare D and Verde P . (1999). Mol. Cell. Biol., 19, 6240–6250.

  • D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S and Pestell RG . (2000). J. Biol. Chem., 275, 32649–32657.

  • Eberhardt W, Pluss C, Hummel R and Pfeilschifter J . (1998). J. Immunol., 160, 4961–4969.

  • Higinbotham KG, Rice JM, Buzard GS and Perantoni AO . (1994). Oncogene, 9, 2455–2459.

  • Ichii S, Takeda S, Horii A, Nakatsuru S, Miyoshi Y, Emi M, Fujiwara Y, Koyama K, Furuyama J, Utsunomiya J and Nakamura Y . (1993). Oncogene, 8, 2399–2405.

  • Inoue Y, Kashima Y, Aizawa K and Hatakeyama K . (1991). Jpn. J. Cancer Res., 82, 90–97.

  • Iritani A, Katayama N, Tahira T, Hayashi K and Tsuchida N . (1986). Bull. Tokyo Med. Dent. Univ., 33, 35–40.

  • Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S . (1995). Proc. Natl. Acad. Sci. USA, 92, 4392–4396.

  • Jiang B, Brecher P and Cohen RA . (2001). Arterioscler. Thromb. Vasc. Biol., 21, 1915–1920.

  • Kawasaki K, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y and Yokoyama KK . (2000). Nature, 405, 195–200.

  • Kawamori T, Takahashi M, Watanabe K, Ohta T, Nakatsugi S, Sugimura T and Wakabayashi K . (2000). Cancer Lett., 148, 33–37.

  • Keinanen R, Vartiainen N and Koistinaho J . (1999). Gene, 234, 297–305.

  • Kiechle FL and Malinski T . (1996). Ann. Clin. Lab. Sci., 26, 501–511.

  • Kojima M, Morisaki T, Izuhara K, Uchiyama A, Matsunari Y, Katano M and Tanaka M . (2000). Oncogene, 19, 1225–1231.

  • Liu CY, Wang CH, Chen TC, Lin HC, Yu CT and Kuo HP . (1998). Br. J. Cancer, 78, 534–541.

  • Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD and Powell DW . (2002). Am. J. Physiol. Cell. Physiol., 282, C824–834.

  • Naka M, Nanbu T, Kobayashi K, Kamanaka Y, Komeno M, Yanase R, Fukutomi T, Fujimura S, Seo HG, Fujiwara N, Ohuchida S, Suzuki K, Kondo K and Taniguchi N . (2000). Biochem. Biophys. Res. Common., 270, 663–667.

  • Norris JL and Baldwin Jr AS . (1999). J. Biol. Chem., 274, 13841–13846.

  • Pahan K, Liu X, McKinney MJ, Wood C, Sheikh FG and Raymond JR . (2000). J. Neurochem., 74, 2288–2295.

  • Pahan K, Sheikh FG, Namboodiri AM and Singh I . (1997). J. Clin. Invest., 100, 2671–2679.

  • Quaroni A, Wands J, Trelstad RL and Isselbacher KJ . (1979). J. Cell Biol., 80, 248–265.

  • Rahmani M, Peron P, Weitzman J, Bakiri L, Lardeux B and Bernuau D . (2001). Oncogene, 20, 5132–5142.

  • Rao CV, Kawamori T, Hamid R and Reddy BS . (1999). Carcinogenesis, 20, 641–644.

  • Schreiber E, Matthias P, Muller MM and Schaffner W . (1989). Nucleic Acids Res., 17, 6419.

  • Shao J, Sheng H, Inoue H, Morrow JD and DuBois RN . (2000). J. Biol. Chem., 275, 33951–33956.

  • Sheng H, Shao J and DuBois RN . (2001). Cancer Res., 61, 2670–2675.

  • Singh K, Balligand JL, Fischer TA, Smith TW and Kelly RA . (1996). J. Biol. Chem., 271, 1111–1117.

  • Slice LW, Bui L, Mak C and Walsh JH . (2000). Biochem. Biophys. Res. Commun., 276, 406–410.

  • Takahashi M, Fukuda K, Ohata T, Sugimura T and Wakabayashi K . (1997). Cancer Res., 57, 1233–1237.

  • Takahashi M, Mutoh M, Kawamori T, Sugimura T and Wakabayashi K . (2000). Carcinogenesis, 21, 1319–1327.

  • Tannous M, Amin R, Popoff MR, Fiorentini C and Kowluru A . (2001). Biochem. Pharmacol., 62, 1459–1468.

  • Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ and Frend AJ . (1997). Cancer Res., 57, 3300–3304.

  • Vickers SM, MacMillan-Crow LA, Green M, Ellis C and Thompson JA . (1999). Arch. Surg., 134, 245–251.

  • Yamashita N, Minamoto T, Ochiai A, Onda M and Esumi H . (1995). Gastroenterology, 108, 434–440.

Download references

Acknowledgements

This work was supported in part by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), grants-in-aid for Cancer Research and for the Second-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan, and a grant for the Research on Advanced Medical Technology from the Ministry of Health, Labour, and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mami Takahashi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, M., Mutoh, M., Shoji, Y. et al. Transfection of K-rasAsp12 cDNA markedly elevates IL-1β- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells. Oncogene 22, 7667–7676 (2003). https://doi.org/10.1038/sj.onc.1207051

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207051

Keywords

This article is cited by

Search

Quick links